Abstract
We have used a proteomic approach using mass spectrometry to identify signaling molecules involved in receptor tyrosine kinase signaling pathways. Using affinity purification by anti-phosphotyrosine antibodies to enrich for tyrosine phosphorylated proteins, we have identified a novel signaling molecule in the epidermal growth factor receptor signaling pathway. This molecule, designated Odin, contains several ankyrin repeats, two sterile alpha motifs and a phosphotyrosine binding domain and is ubiquitously expressed. Using antibodies against endogenous Odin, we show that it undergoes tyrosine phosphorylation upon addition of growth factors such as EGF or PDGF but not by cytokines such as IL-3 or erythropoietin. Immunofluorescence experiments as well as Western blot analysis on subcellular fractions demonstrated that Odin is localized to the cytoplasm both before and after growth factor treatment. Deletion analysis showed that the phosphotyrosine binding domain of Odin is not required for its tyrosine phosphorylation. Overexpression of Odin, but not an unrelated adapter protein, Grb2, inhibited EGF-induced activation of c-Fos promoter. Microinjection of wild-type or a mutant version lacking the PTB domain into NIH3T3 fibroblasts inhibited PDGF-induced mitogenesis. Taken together, our results indicate that Odin may play a negative role in growth factor receptor signaling pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- EGFR:
-
epidermal growth factor receptor
- MS/MS:
-
tandem mass spectrometry
- PTB:
-
phosphotyrosine binding domain
- SH2:
-
src homology 2
References
Biemann K . 1988 Biomed. Environm. Mass Spectrom. 16: 99–111
Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B . 1994 J. Biol. Chem. 269: 32031–32034
Burack WR, Shaw AS . 2000 Curr. Opin. Cell. Biol. 12: 211–216
Curran T, Bravo R, Muller R . 1985 Cancer Surv. 4: 655–681
Darnell Jr JE . 1997 Science 277: 1630–1635
Del Sal G, Ruaro ME, Philipson L, Schneider C . 1992 Cell 70: 595–607
Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ . 1995 Mol. Cell. Biol. 15: 2500–2508
Hunter T, Cooper JA . 1985 Annu. Rev. Biochem. 54: 897–930
Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, Hibi M, Nakabeppu Y, Shiba T, Yamamoto KI . 1999 Mol. Cell. Biol. 19: 7539–7548
Kavanaugh WM, Williams LT . 1994 Science 266: 1862–1865
Kazlauskas A, Cooper JA . 1989 Cell 58: 1121–1133
Lavery DJ, Schibler U . 1993 Genes Dev. 7: 1871–1884
Leonard WJ, O'Shea JJ . 1998 Annu. Rev. Immunol. 16: 293–322
Manes G, Bello P, Roche S . 2000 Mol. Cell. Biol. 20: 3396–3406
Mann M, Wilm M . 1994 Anal. Chem. 66: 4390–4399
Margolis B . 1999 Trends Endocrinol. Metab. 10: 262–267
Muller R, Bravo R, Burckhardt J, Curran T . 1984 Nature 312: 716–720
Nagase T, Seki N, Ishikawa K, Ohira M, Kawarabayasi Y, Ohara O, Tanaka A, Kotani H, Miyajima N, Nomura N . 1996 DNA Res. 3: 321–329
Nakai K, Kanehisa M . 1992 Genomics 14: 897–911
Pandey A, Podtelejnikov AV, Blagoev B, Bustelo XR, Mann M, Lodish HF . 2000a Proc. Natl. Acad. Sci. USA 97: 179–184
Pandey A, Fernandez MM, Steen H, Blagoev B, Nielsen MM, Roche S, Mann M, Lodish HF . 2000b J. Biol. Chem. 275: 37633–37639
Pandey A, Andersen JS, Mann M . 2000c Sci. STKE 2000: PL1
Pawson T . 1994 Princess Takamatsu Symp. 24: 303–322
Pawson T, Scott JD . 1997 Science 278: 2075–2080
Ponting CP . 1995 Protein Sci. 4: 1928–1930
Richard S, Yu D, Blumer KJ, Hausladen D, Olszowy MW, Connelly PA, Shaw AS . 1995 Mol. Cell. Biol. 15: 186–197
Roche S, Fumagalli S, Courtneidge SA . 1995 Science 269: 1567–1569
Roepstorff P, Fohlman J . 1984 Biomed. Mass Spectrom. 11: 601
Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ . 1998 Science 281: 1668–1671
Schultz J, Milpetz F, Bork P, Ponting CP . 1998 Proc. Natl. Acad. Sci. USA 95: 5857–5864
Sedgwick SG, Smerdon SJ . 1999 Trends Biochem. Sci. 24: 311–316
Shevchenko A, Jensen ON, Podtelejnikov AV, Sagliocco F, Wilm M, Vorm O, Mortensen P, Boucherie H, Mann M . 1996a Proc. Natl. Acad. Sci. USA 93: 14440–14445
Shevchenko A, Wilm M, Vorm O, Mann M . 1996b Anal. Chem. 68: 850–858
Smalla M, Schmieder P, Kelly M, Ter Laak A, Krause G, Ball L, Wahl M, Bork P, Oschkinat H . 1999 Protein Sci. 8: 1954–1961
Steen H, Kuster B, Fernandez M, Pandey A, Mann M . 2002 J. Biol. Chem. 277: 1031–1039
Ullrich A, Schlessinger J . 1990 Cell 61: 203–212
van der Geer P, Hunter T, Lindberg RA . 1994 Annu. Rev. Cell Biol. 10: 251–337
van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T . 1995 Curr. Biol. 5: 404–412
Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ . 1998 Science 281: 1671–1674
Wilm M, Shevchenko A, Houthaeve T, Breit S, Schweigerer L, Fotsis T, Mann M . 1996 Nature 379: 466–469
Yaich L, Ooi J, Park M, Borg JP, Landry C, Bodmer R, Margolis B . 1998 J. Biol. Chem. 273: 10381–10388
Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ . 1999 Mol. Cell. Biol. 19: 7245–7254
Acknowledgements
Work at the Center for Experimental Bioinformatics is supported by a generous grant from the Danish National Research Foundation to the Center for Experimental Bioinformatics (CEBI) at the University of Southern Denmark. A Pandey is supported by a Howard Temin Award from the National Cancer Institute (KO1 CA75447) and by a travel award from the Plasmid Foundation, Roskilde, Denmark. We thank Drs Stuart Decker and Andrius Kazlauskas for providing constructs for EGFR and PDGFR respectively. We would also like to thank Dr Stéphane Richard for the Grb2 expression vector.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pandey, A., Blagoev, B., Kratchmarova, I. et al. Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases. Oncogene 21, 8029–8036 (2002). https://doi.org/10.1038/sj.onc.1205988
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205988
Keywords
This article is cited by
-
Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis
Nature Communications (2016)
-
Proteomic dissection of biological pathways/processes through profiling protein-protein interaction networks
Science China Chemistry (2010)
-
Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells
Cell Communication and Signaling (2008)
-
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
Nature Biotechnology (2005)
-
Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics
Nature Biotechnology (2004)